Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Modified DNA Aptamer That Binds the ( R )-Isomer of a Thalidomide Derivative with High Enantioselectivity
2007
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Advances in stem cell mobilization
2014
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
2002 Standout
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
1999
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients
1998
Hydroxychloroquine for the treatment of chronic graft-versus-host disease
2000
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Cutaneous Graft-versus-Host Disease
1998
Neutrophils at work
2014 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Chronic graft-versus-host disease: clinical manifestation and therapy
2001
The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients
1998
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Advances in stem cell mobilization
2012
Infections in adults undergoing unrelated donor bone marrow transplantation
1999
The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
1998
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients
2002
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation
2004
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Apophysomyces elegans infection in a renal transplant recipient
1995
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
1996
Response to thalidomide therapy in refractory chronic graft-versus-host disease
2000
Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: A single center experience from 1980 to 1995
1996
Therapeutic Outcome in Invasive Aspergillosis
1996
Vascular disorders of the liver # †
2008 Standout
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Chronic graft-versus-host disease
2003 Standout
Chronic myelogenous leukemia: A review
1996
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Invasive Aspergillosis in Transplant Recipients
1999
A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
2004
Glucocorticoids and invasive fungal infections
2003
Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial
1996
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Inflammatory Bowel Disease
2002 Standout
Ganciclovir
2001
Graft-versus-host disease
2009 Standout
PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE
1999
Echinocandin antifungal drugs
2003 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Circos: An information aesthetic for comparative genomics
2009 Standout
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
2000
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
1999
Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia
1997
Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation
1999
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)
2007
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation
2000
A review of autologous hematopoietic cell transplantation
2000 Nobel
Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital
2002
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
2001
Invasive Mold Infections in Allogeneic Bone Marrow Transplant Recipients
2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation
2001
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
2000
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
The thalidomide saga
2007
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
2001
Functional Nucleic Acid Sensors
2009 Standout
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Zygomycetes in Human Disease
2000 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial
2003
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
AspergillusInfections in Transplant Recipients
2005
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial.
1999
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation.
2000
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Thalidomide for treatment of patients with chronic graft-versus-host disease
2000
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Novel therapeutics for the treatment of graft-versus-host disease
2002
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Hodgkin's lymphoma
2003
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Treatment of Chronic Graft-Versus-Host Disease With Clofazimine
1997
Cytokine-induced radiation protection and sensitization
1996
Works of EP Smith being referenced
Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir
1997
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
1994
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
1994
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission
2000
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
1995
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase
1994
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors
1995